Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

Lpath, Inc. CEO to Present Live, Online at RetailInvestorConferences.com on May 5th

May 2, 2011 12:38 pm | by Bio-Medicine.Org | News | Comments

NEW YORK, May 2, 2011 /- Lpath, Inc. (OTCBB: LPTN), the category leader in bioactive-lipid-targeted therapeutics, today announced that Scott Pancoast, Lpath President and CEO, will present at RetailInvestorConferences.com.DATE: May 5th, 2011TIME: 3:00 PM EDTLINK:...

Nonin Medical Announces Mark VanderWerf, Vice President-eHealth, Elected to American Telemedicine Association College of Fellows

May 2, 2011 12:36 pm | by Bio-Medicine.Org | News | Comments

MINNEAPOLIS, May 2, 2011 /- Nonin Medical, Inc., the inventor of finger pulse oximetry and a leader in noninvasive medical monitoring, today announced that Mark VanderWerf, Nonin's Vice President of eHealth, has been elected to the American Telemedicine Association (ATA) College of...

Baylor Heart and Vascular Hospital Announces First Patient Procedure in the United States to Treat Atrial Fibrillation Using New Catheter for Cryoablation Technology

May 2, 2011 12:34 pm | by Bio-Medicine.Org | News | Comments

DALLAS, May 2, 2011 /PRNewswire-USNewswire/ -- Baylor Jack and Jane Hamilton Heart and Vascular Hospital today announced the first patient procedure in the U.S. using the Achieve™ Mapping Catheter, an intra-cardiac electrophysiology diagnostic catheter that can be used to assess...

Advertisement

CMC Biologics Announces Appointment of New CEO

May 2, 2011 11:35 am | by Bio-Medicine.Org | News | Comments

COPENHAGEN, Denmark and SEATTLE, May 2, 2011 /- CMC Biologics, a leading biopharmaceutical Contract Manufacturing Organization, with operations in Copenhagen, Denmark and Seattle, Washington USA, announced today that it has hired Claes Glassell to serve at its Chief Executive Officer. CMC...

Hill-Rom to Participate in the Bank of America Merrill Lynch Health Care Conference

May 2, 2011 11:35 am | by Bio-Medicine.Org | News | Comments

BATESVILLE, Ind., May 2, 2011 /- Hill-Rom Holdings, Inc., (NYSE: HRC ) invites you to listen to a management presentation at the Bank of America Merrill Lynch Health Care Conference in Las Vegas on May 10, 2011, at 2:20 p.m. EDT. You are invited to listen to the live discussion via the...

NMT Medical, Inc. Assigned All Its Assets to Joseph F. Finn, Jr., C.P.A. of the Firm Finn, Warnke & Gayton, LLP on April 20, 2011

May 2, 2011 9:33 am | by Bio-Medicine.Org | News | Comments

WELLESLEY HILLS, Mass., May 2, 2011 /- On April 20, 2011, NMT Medical, Inc. ("NMT Medical") assigned all its assets to Joseph F. Finn, Jr., C.P.A. ("Finn") of the firm Finn, Warnke & Gayton, LLP to be liquidated for the benefit of NMT Medical creditors. NMT Medical's intellectual...

Generex Biotechnology Corporation CEO to Present Live, Online at RetailInvestorConferences.com on May 5th

May 2, 2011 9:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, May 2, 2011 /- Generex Biotechnology Corporation ( www.generex.com ) (OTC: GNBT) today announced that Mark Fletcher, CEO, will present at RetailInvestorConferences.com. DATE: May 5th, 2011 TIME:  11:00 AM EDT LINK: www.retailinvestorconferences.com >Click the red...

Perrigo Announces FDA Final Approval for Minoxidil Foam - Generic Equivalent to Men's Rogaine® Foam

May 2, 2011 9:32 am | by Bio-Medicine.Org | News | Comments

ALLEGAN, Mich., May 2, 2011 /- Perrigo Company (Nasdaq: PRGO ; TASE) today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for over-the-counter (OTC) Minoxidil Foam, a generic version of Men's Rogaine®...

Advertisement

Michigan Growth Capital Symposium Unveils Robust Line Up of Presenting Companies for 30th Anniversary Event

May 2, 2011 8:35 am | by Bio-Medicine.Org | News | Comments

ANN ARBOR, Mich., May 2, 2011 /- Anticipating record attendance among the investment community at the upcoming Michigan Growth Capital Symposium , taking place May 10-11 at the Marriott Resort in Ypsilanti, Mich., event organizers today unveiled the complete list of companies that will...

Prexa names Graham, Reines to executive staff

May 2, 2011 8:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Prexa Pharmaceuticals Inc., a Boston biotech focused on developments to treat central nervous system disorders, has appointed Evelyn Graham as chief operating officer and Scott Reines as chief medical officer.

Aoxing Pharmaceutical Company Announces Issuance of Chinese Patent for Naloxone Sublingual Film

May 2, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

JERSEY CITY, N.J., May 2, 2011 /- Aoxing Pharmaceutical (NYSE Amex: AXN ) ("Aoxing Pharma"), a specialty pharmaceutical company focusing on research, development, manufacturing and distribution of narcotic and pain-management products, announced that its operating subsidiary in China,...

SeraCare Life Sciences Announces Renewal of National Institutes of Health Contract to Support Research

May 2, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

MILFORD, Mass., May 2, 2011 /- SeraCare Life Sciences announced today that the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has awarded a new contract to SeraCare, replacing the current contract which expired on April 30, 2011. Under this...

City Medical, PC Adds Digital X-ray Machine

May 2, 2011 8:33 am | by Bio-Medicine.Org | News | Comments

MADISON HEIGHTS, Mich., May 2, 2011 /- City Medical, P.C., the principal provider of high-quality, community-focused health care for Madison Heights and Southgate, Michigan, today announced that it has added a new digital X-ray machine at its Madison Heights office . The new Agfa-Viztek...

Advertisement

NewCardio to Showcase Cardiac Diagnostic Technology at MDB Capital's Bright Lights Conference in New York City on May 10, 2011

May 2, 2011 8:33 am | by Bio-Medicine.Org | News | Comments

SANTA CLARA, Calif., May 2, 2011 /- NewCardio, Inc., (OTC BB: NWCI) a cardiac diagnostic technology provider, today announced its selection for the prestigious NYC Bright Lights Conference at the Le Parker Meridien Hotel in New York City. Bright Lights is the only conference of its...

Volcano Corporation Presentation at JMP Securities Conference to be Webcast

May 2, 2011 8:33 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, May 2, 2011 /- Volcano Corporation (NASDAQ: VOLC ), a leading developer and manufacturer of precision intravascular diagnosis and therapy guidance tools designed to enhance the treatment of coronary and peripheral vascular disease, said today that it will be participating in...

Regenerect: Recall - Undeclared Drug Ingredient

May 2, 2011 8:30 am | by U.S. Food & Drug Administration | News | Comments

Product marketed as dietary supplement contain drug ingredient sulfoaildenafil, which may interact with nitrates found in some prescription drugs and lower blood pressure to dangerous levels.

SeraCare renews $17M federal research-support contract

May 2, 2011 7:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

SeraCare Life Sciences Inc., a Milford provider of products and services that support drug discovery and medical device development, has won a contract renewal, worth about $17.6 million over five years, from the National Heart, Lung, and Blood Institute of the National Institutes of Health.

PositiveID Corporation and VGo Communications to Host Joint Demonstration of Wireless Health Solutions at American Telemedicine Association Conference

May 2, 2011 5:31 am | by PositiveID | News | Comments

PositiveID Corporation and VGo Communications to Host Joint Demonstration of Wireless Health Solutions at American Telemedicine Association Conference

Boston Scientific Announces Its Schedule for Heart Rhythm Society Scientific Sessions

May 2, 2011 4:34 am | by Boston Scientific | News | Comments

NATICK, Mass., May 2, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced its schedule of major events and sponsored research at the 32nd Annual Scientific Sessions of the Heart Rhythm Society (HRS)

Federal Register: Reprocessing of Reusable Medical Devices; Public Workshop

May 2, 2011 4:30 am | by U.S. Food & Drug Administration | News | Comments

The Food and Drug Administration (FDA) is announcing a public workshop entitled: "Reprocessing of Reusable Medical Devices Workshop.' The purpose of the workshop is to discuss factors affecting the reprocessing of reusable medical devices

Federal Register: Draft Guidance for Industry and FDA Staff; Availability: Processing/Reprocessing Medical Devices in Health Care Settings; Validation Methods and Labeling

May 2, 2011 4:30 am | by U.S. Food & Drug Administration | News | Comments

The Food and Drug Administration (FDA) is announcing the availability of the draft guidance document entitled "Draft Guidance for Industry and FDA Staff: Processing/Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling."

IRIDEX Granted U.S. Patent for Stepped Angled Laser Handpieces Used in Eye Surgery

May 2, 2011 3:37 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., May 2, 2011 /- IRIDEX Corporation (Nasdaq: IRIX ) today announced that the U.S. Patent and Trademark Office had issued to IRIDEX a patent applying to a group of specially designed laser handpieces used in invasive ophthalmic surgical procedures. The patent, No....

Henry Schein to Present at Deutsche Bank 36th Annual Health Care Conference

May 2, 2011 3:36 am | by Bio-Medicine.Org | News | Comments

MELVILLE, N.Y., May 2, 2011 /- Henry Schein, Inc., (NASDAQ: HSIC ), the largest provider of health care products and services to office-based practitioners, announced today that Stanley M. Bergman, Chairman and Chief Executive Officer of Henry Schein, and Steven Paladino, the Company's...

Abaxis Appoints Vernon Altman to Board of Directors

May 2, 2011 3:36 am | by Bio-Medicine.Org | News | Comments

UNION CITY, Calif., May 2, 2011 /- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, today announced Vernon Altman has been appointed to the Company's Board of Directors, effective immediately. The addition of Mr. Altman brings...

BioBehavioral Diagnostics takes in $300,000

May 2, 2011 3:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

BioBehavioral Diagnostics Co., which makes a medical device for attention deficit hyperactivity disorder (ADHD), has raised $300,000 in a sale of $500,000 in securities.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading